Effect of oral versus transdermal steroidal contraceptives on androgenic markers

American Journal of Obstetrics and Gynecology

Volumn 192, Issue 6, 2005, Pages 2055-2059

  White, Terry ^a,b   Jain, John K ^a   Stanczyk, Frank Z ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b NONE   (United States)

Author keywords

Androgens; Contraceptive patch; Oral contraceptives; Sex hormone binding globulin; Testosterone

Indexed keywords

ANDROGEN; ANDROSTANE DERIVATIVE; ANDROSTANEDIOL GLUCURONIDE; ANDROSTANOLONE; ANDROSTENEDIONE; CONTRACEPTIVE AGENT; ETHINYLESTRADIOL PLUS NORELGESTROMIN; ETHINYLESTRADIOL PLUS NORGESTIMATE; PRASTERONE SULFATE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; UNCLASSIFIED DRUG;

ADULT; ANDROSTENEDIONE BLOOD LEVEL; BLOOD SAMPLING; CALCULATION; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HORMONAL CONTRACEPTION; HORMONE BLOOD LEVEL; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; SAMPLE SIZE; STATISTICAL ANALYSIS; STATISTICAL MODEL; STATISTICAL SIGNIFICANCE; STUDENT T TEST; TESTOSTERONE BLOOD LEVEL;

ADMINISTRATION, CUTANEOUS; ADOLESCENT; ADULT; ANDROGENS; ANDROSTENEDIONE; CONTRACEPTIVE AGENTS, FEMALE; CONTRACEPTIVES, ORAL, COMBINED; DEHYDROEPIANDROSTERONE SULFATE; DIHYDROTESTOSTERONE; ETHINYL ESTRADIOL; ETHISTERONE; FEMALE; HUMANS; NORGESTREL; OXIMES; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE; TREATMENT OUTCOME;

EID: 20444473488     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2005.02.067     Document Type: Conference Paper

References (25)

1. I.H. Thorneycroft, F.Z. Stanczyk, K.D. Bradshaw, S.A. Ballagh, M. Nichols, and Weber M.E. Effect of low-dose oral contraceptives on androgenic markers and acne Contraception 60 1999 255 262
2. D.M. Breitkopf, P.R. Mitchell, S.L. Young, and M. Nagamani Efficacy of second versus third generation oral contraceptives in the treatment of hirsutism Contraception 67 2003 349 353
3. C.M.H. Coenen, C.M.G. Thomas, G.F. Borm, and R. Rolland Comparative evaluation of the androgenicity of four low-dose, fixed-combination oral contraceptives Int J Fertil 40 Suppl 2 1995 92 97
4. G.P. Redmond, W.H. Olson, J.S. Lippman, M.E. Kafrissen, T.M. Jones, and J.L. Jorizzo Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: a randomized, placebo-controlled trial Obstet Gynecol 89 1997 615 622
5. R.T. Burkman The transdermal contraceptive system Am J Obstet Gynecol 190 2004 S49 S53
6. U. Goebelsmann, G.S. Bernstein, J.A. Gale, O.A. Kletzky, R.M. Nakamura, and A.H. Coulson Serum gonadotropin testosterone estradiol and estrone levels prior to and following bilateral vasectomy I.H. Lepow R. Crozier Vasectomy: immunologic and pathophysiologic effects in animals and man 1979 Academic Press New York 165 175
7. U. Goebelsmann, J.J. Arce, I.H. Thorneycroft, and D.R. Mishell Jr. Serum testosterone concentrations in women throughout the menstrual cycle and following hCG administration Am J Obstet Gynecol 119 1974 445 452
8. U. Goebelsmann, R. Horton, J.H. Mestman, J.J. Arce, Y. Nagata, and R.M. Nakamura Male pseudohermaphroditism due to testicular 17-hydroxysteroid dehydrogenase deficiency J Clin Endocrinol Metab 36 1973 867
9. P. Serafini, F. Ablan, and R.A. Lobo 5α-Reductase activity in the genital skin of hirsute women J Clin Endocrinol Metab 60 1985 349
10. Narang R, Rao J, Savjani G, Peterson J, Gentzschein E, Stanczyk FZ. Radioimmunoassay kit for the quantitative measurement of androstanediol glucuronide in unextracted serum. Poster presented at: 17th National Meeting of the Clinical Ligand Assay Society; April 10-13, 1991; Chicago, Ill.
11. R. Sodergard, T. Backstrom, V. Shanbhag, and H. Carstensen Calculation of free and bound fractions of testosterone and estradiol-17b to human plasma protein at body temperature J Steroid Biochem 26 1982 801 810
12. A. Vermeulen, L. Verdonck, and J.M. Kaufman A critical evaluation of simple methods for estimation of free testosterone in serum J Clin Endocrinol Metab 84 1999 3666 3672
13. S. Rinaldi, A. Geay, H. Déchaud, C. Biessy, A. Zeleniuch-Jacquotte, and A. Akhmedkhanov Validity of free testosterone and free estradiol determinations in serum samples from postmenopausal women by theoretical calculations Cancer Epidemiol Biomarkers Prev 11 2002 1065 1071
14. I. Wiegratz, E. Kutschera, J.H. Lee, C. Moore, U. Mellinger, and U.H. Winkler Effect of four different oral contraceptives on various sex hormones and serum binding globulins Contraception 67 2003 25 32
15. N. Van der Vange, M.A. Blankenstein, H.J. Kloosterboer, A.A. Haspels, and J.H.H. Thijssen Effects of seven low-dose combined oral contraceptives on sex hormone binding globulin, corticosteroid binding globulin, total and free testerone Contraception 41 1990 345 352
16. A. Murphy, C.S. Cropp, B.S. Smith, R.T. Burkman, and H.A. Zacur Effect of low-dose oral contraceptive on gonadotropins, androgens, and sex hormone binding globulin in nonhirsute women Fertil Steril 53 1990 35 39
17. R.A. Lobo Hirsutism, alopecia, and acne K.L. Becker Principles and practice of endocrinology and metabolism 2001 Lippincott, Williams and Wilkins Philadelphia 991 1008
18. R.A. Pierson, D.F. Archer, M. Moreau, G.A. Shangold, A.C. Fisher, and G.W. Creasy Ortho Evra versus oral contraceptives: follicular development and ovulation in normal cycles and after an intentional dosing error Fertil Steril 80 2003 34 42
19. V. Odlind, I. Milsom, I. Persson, and A. Victor Can changes in sex hormone binding globulin predict the risk of venous thromboembolism with combined oral contraceptive pills? Acta Obstet Gynecol Scand 81 2002 482 490
20. C. Campagnoli, N. Biglia, F. Altare, M.G. Lanza, L. Lesca, and C. Cantamessa Differential effects of oral conjugated estrogens and transdermal estradiol on insulin-like growth factor 1, growth hormone and sex hormone binding globulin serum levels Gynecol Endocrinol 7 1993 251 258
21. M. Basbug, E. Aygen, M. Tayyar, S. Muhtaroglu, I. Demir, and S. Okten Twenty two weeks of transdermal estradiol increases sex hormone-binding globulin in surgical menopausal women Eur J Obstet Gynecol Reprod Biol 73 1997 149 152
22. L.E. Nachtigall, U. Raju, S. Banerjee, L. Wan, and M. Levitz Serum estradiol-binding profiles in postmenopausal women undergoing three common estrogen replacement therapies: associations with sex hormone-binding globulin, estradiol, and estrone levels Menopause 7 2000 243 250
23. I.S. Serin, B. Ozcelik, M. Basbug, E. Aygen, M. Kula, and R. Erez Long-term effects of continuous oral and transdermal estrogen replacement therapy on sex hormone binding globulin and free testosterone levels Eur J Obstet Gynecol Reprod Biol 99 2001 222 225
24. M. Van Rooijen, A. Silveira, A. Hamsten, and K. Bremme Sex hormone-binding globulin - a surrogate marker for the prothrombotic effects of combined oral contraceptives Am J Obstet Gynecol 190 2004 332 337
25. L.S. Abrams, D. Skee, J. Natarajan, and F.A. Wong Pharmacokinetic overview of Ortho Evra™/Evra™ Fertil Steril 77 Suppl 2 2002 S3 S12